Healthcare >> CEO Interviews >> March 19, 2001
PAUL EDWARDS is the Chief Executive Officer of GeneMedix Plc. Mr
Edwards, aged 44, was appointed to the Board in December 1999. He was
formerly Vice President and General Manager of Genzyme Corporation's UK
operation. A graduate in Chemistry from Surrey University, he spent
seven years with Beecham Pharmaceuticals involved in the manufacture of
semi-synthetic penicillins, before moving to Genzyme in 1986. Most
recently, he has worked in management consultancy at Ruston Poole
International. Mr Edwards is the former Chairman of the Manufacturing
Advisory Committee of the UK BioIndustry Association, and has worked
with the UK Department of Trade and Industry advising on issues relating
to the manufacture of biopharmaceuticals. In 1997, he received an MBE
for services to biotechnology and in 1999, the Donald Medal for services
to biochemical engineering. Profile
GeneMedix?
Mr. Edwards: GeneMedix was founded in 1997 to develop, manufacture and
market a range of generic versions of
